Abbott Laboratories (ABT) EBT Margin (2009 - 2026)
Abbott Laboratories (ABT) reported EBT Margin of 12.98% for Q1 2026, down 419.0% on a YoY basis from 4.07% in Q1 2025, and down 36.93% sequentially from 20.58% in Q4 2025.
Abbott Laboratories (ABT) EBT Margin (2009 - 2026) Analysis & Trends
Abbott Laboratories (ABT) has 18 years of EBT Margin data on file, last reported at 12.98% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 419.0% year-over-year to 12.98%; the trailing twelve-month figure through Mar 2026 stood at 18.03% (up 66.0% YoY), and the FY2025 full-year result was 19.1%, up 238.0% from the prior year.
- EBT Margin fell to 12.98% in Q1 2026, from 20.58% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 24.18% in Q1 2022 to a low of 12.98% in Q1 2026.
- A 5-year average of 17.49% and a median of 17.17% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin surged 771 bps in 2022 and plunged 815 bps in 2023, its largest moves.
- Tracing ABT's EBT Margin over 5 years: stood at 13.08% in 2022, then surged by 34 bps to 17.53% in 2023, then advanced by 6 bps to 18.5% in 2024, then gained by 11 bps to 20.58% in 2025, then slumped by 37 bps to 12.98% in 2026.
- Business Quant data shows ABT's EBT Margin at 12.98% in Q1 2026, 20.58% in Q4 2025, and 19.17% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 18.70% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 27.84% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 22.61% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 4.87% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.84% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Steris | 20.59 Bn | 20.16 Bn | 697.10 Mn | 19.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.98% |
| Dec 31, 2025 | 20.58% |
| Sep 30, 2025 | 19.17% |
| Jun 30, 2025 | 19.30% |
| Mar 31, 2025 | 17.17% |
| Dec 31, 2024 | 18.50% |
| Sep 30, 2024 | 18.24% |
| Jun 30, 2024 | 15.49% |
| Mar 31, 2024 | 14.41% |
| Dec 31, 2023 | 17.53% |
| Sep 30, 2023 | 16.47% |
| Jun 30, 2023 | 16.40% |
| Mar 31, 2023 | 16.03% |
| Dec 31, 2022 | 13.08% |
| Sep 30, 2022 | 16.89% |
| Jun 30, 2022 | 20.89% |
| Mar 31, 2022 | 24.18% |
| Dec 31, 2021 | 20.29% |
| Sep 30, 2021 | 22.81% |
| Jun 30, 2021 | 13.19% |